Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinzhen oral liquid dose-ranging add-on study with azithromycin in children with Mycoplasma pneumoniae pneumonia
ChiCTR1800019007Phase 4Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2017
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jinzhen and azithromycin in Mycoplasmal pneumonia (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Time of clinical recovery. Started Sep 2017; status: recruiting.
02
Drugs
Jinzhenazithromycin
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on ChiCTR1800019007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019007.